Skip to content
healthcare.dev

MEDROXYPROGESTERONE ACETATE

NDC 55150-330, MEDROXYPROGESTERONE ACETATE, injection, suspension, from Eugia US LLC.

Product NDC
55150-330
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212844
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-330 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEDROXYPROGESTERONE ACETATE150 mg/mL

Pharmacologic classes

Progesterone Congeners [CS]; Progestin [EPC]

Package NDCNDC-11Package
55150-330-01551500330011 SYRINGE in 1 CARTON (55150-330-01) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0655670a-d127-4e08-8a23-ace64b2503b2
  • NADAC price for package 55150033001

    GET /v1/drugs/nadac/55150033001

Use it

Look up 55150-330 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-330 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-330. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.